Page 269 - Eshre Final Programme 2015

P-647 Differences in chromosomal abnormalities observed in preimplantation embryos according to male or female meiosis disruption in isolated male factor (MF) and advanced maternal age (AMA) C. Rubio1, L. Rodrigo1, M. Florensa2, E. Mateu1, A. Mercader3, V. Peinado1, F. Bronet4,
M. Milan1, S. Garcia-Herrero1, I. Campos-Galindo1, C. Simon5
1IGENOMIX, PGD, Paterna-Valencia, Spain
2IVI Barcelona, Embryology, Barcelona, Spain 3IVI Valencia, PGD, Valencia, Spain
4IVI Madrid, Embryology and PGD, Madrid, Spain
5Fundación Instituto Valenciano de Infertilidad (FIVI) Instituto Universitario IVI/INCLIVA Valencia University Department of Obstetrics and Gynecology School of Medicine Stanford University IGENOMIX, Reproductive Medicine, Paterna-Valencia, Spain
P-648 CGH is mainly worth for older patients: comparison of outcomes on unselected patients receiving frozen-thawed blastocysts from elective cycles with or not day 5/6 CGH-biopsies.
M. Nicolielo1, M. Piccolomini1, N. Nobrega1, E. Semaco2, J.R. Alegretti1, B.C. Barros1,
P.C. Serafini3, T.C.S. Bonetti4, E.L.A. Motta5
1Huntington Reproductive Medicine, Embryology, Sao Paulo, Brazil
2Huntington Reproductive Medicine, Andrology Laboratory, Sao Paulo, Brazil
3Huntington Reproductive Medicine / Obstetrics and Gynecology Department of University of Sao Paulo, Head of Clinical / Gynecology Discipline - Assisted Reproduction Center, Sao Paulo, Brazil
4Gynecology Department of Federal University of Sao Paulo, Gynecology-endocrinology Discipline, Sao Paulo, Brazil
5Huntington Reproductive Medicine Gynecology Department of Federal University of Sao Paulo, Head of Clinical Gynecology-endocrinology Discipline, Sao Paulo, Brazil
P-649 Are false positive rates comparable at day-3 blastomere versus day-5 trophoectoderm biopsies using arrayCGH for Preimplantation Genetic Screening?
P. Mir Pardo1, E. Mateu1, A. Mercader2, R. Herrer3, L. Rodrigo4, M. Vera1, V. Peinado1, M. Milán-Sánchez1, I. Campos-Galindo1, S. García-Herrero1, C. Simón5, C. Rubio4
1IGENOMIX Valencia (Spain), PGD, Valencia, Spain
2FIVI-Valencia/INCLIVA (Spain) and IVI- Valencia (Spain), FIV, Valencia, Spain
3IVI- Zaragoza (Spain), FIV, Valencia, Spain
4IGENOMIX Valencia (Spain) and FIVI-Valencia/INCLIVA (Spain), PGD, Valencia, Spain
5Fundación Instituto Valenciano de Infertilidad (FIVI) Instituto Universitario IVI/INCLIVA Valencia University Department of Obstetrics and Gynecology School of Medicine Stanford University., Reproductive Medicine, Valencia, Spain
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 269
POSTERS